Society for Cardiovascular Angiography and Interventions
Restructuring needed to combat backlog of interventional procedures due to pandemic
Excess CV mortality due to the pandemic has been observed globally, and clinicians may need to consider restructuring services to meet the backlog of patients on the waiting list to undergo lifesaving interventions, a speaker reported.
SCAI updates cath lab best practices for delivery of high-quality care
The Society for Cardiovascular Angiography and Interventions has updated its guideline on best practices in the cardiac catheterization laboratory.
TAVR programs concentrated in wealthier areas, raising questions about access
There are inequities in the dispersion of transcatheter aortic valve replacement, with lower rates in poorer communities, according to a presentation.
ISCHEMIA population underrepresented among those who undergo PCI for stable CAD
In a cohort of real-world patients with stable ischemic heart disease who underwent PCI, only 14% could be classified similarly to patients from the ISCHEMIA trial, researchers reported.
Severe valvular disease, COVID-19 mortality ‘approaching’ 50% at 30 days
Thirty-day mortality among patients with severe valvular heart disease and COVID-19 topped more than 40%, according to data presented at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Incidence of nontraditional risk factors elevated in younger Black patients with CAD
Black patients with CAD aged 45 years or younger had more nontraditional risk factors than older Black patients with CAD, researchers reported at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions.
At height of pandemic, patients presenting with acute MI dropped drastically
The number of patients presenting with acute MI significantly declined during the peak of the COVID-19 pandemic, according a presentation at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions.
Robotic PCI confers high rates of technical, clinical success
The second generation of a robotic PCI system was associated with high rates of clinical and technical success, according to a presentation at the virtual Society for Cardiovascular Angiography and Interventions Scientific Sessions.
In high-risk ACS, long-term DAPT confers reduced ischemic events without rise in bleeding
Among patients at high ischemic and bleeding risk, longer duration of dual antiplatelet therapy after PCI for ACS was associated with lower risk for adverse events at 30 months vs. shorter duration DAPT, a speaker reported.
Mortality high, PCI common in patients with concomitant STEMI, COVID-19: NACMI Registry
In-hospital mortality remains high and primary PCI is common in patients with STEMI and COVID-19, according to new data from the North American COVID-19 Myocardial Infarction Registry.